Cargando…
Challenges of infectious diseases in the USA
In the USA, infectious diseases continue to exact a substantial toll on health and health-care resources. Endemic diseases such as chronic hepatitis, HIV, and other sexually transmitted infections affect millions of individuals and widen health disparities. Additional concerns include health-care-as...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137922/ https://www.ncbi.nlm.nih.gov/pubmed/24996590 http://dx.doi.org/10.1016/S0140-6736(14)60890-4 |
_version_ | 1783518501746507776 |
---|---|
author | Khabbaz, Rima F Moseley, Robin R Steiner, Riley J Levitt, Alexandra M Bell, Beth P |
author_facet | Khabbaz, Rima F Moseley, Robin R Steiner, Riley J Levitt, Alexandra M Bell, Beth P |
author_sort | Khabbaz, Rima F |
collection | PubMed |
description | In the USA, infectious diseases continue to exact a substantial toll on health and health-care resources. Endemic diseases such as chronic hepatitis, HIV, and other sexually transmitted infections affect millions of individuals and widen health disparities. Additional concerns include health-care-associated and foodborne infections—both of which have been targets of broad prevention efforts, with success in some areas, yet major challenges remain. Although substantial progress in reduction of the burden of vaccine-preventable diseases has been made, continued cases and outbreaks of these diseases persist, driven by various contributing factors. Worldwide, emerging and reemerging infections continue to challenge prevention and control strategies while the growing problem of antimicrobial resistance needs urgent action. An important priority for control of infectious disease is to ensure that scientific and technological advances in molecular diagnostics and bioinformatics are well integrated into public health. Broad and diverse partnerships across governments, health care, academia, and industry, and with the public, are essential to effectively reduce the burden of infectious diseases. |
format | Online Article Text |
id | pubmed-7137922 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71379222020-04-07 Challenges of infectious diseases in the USA Khabbaz, Rima F Moseley, Robin R Steiner, Riley J Levitt, Alexandra M Bell, Beth P Lancet Article In the USA, infectious diseases continue to exact a substantial toll on health and health-care resources. Endemic diseases such as chronic hepatitis, HIV, and other sexually transmitted infections affect millions of individuals and widen health disparities. Additional concerns include health-care-associated and foodborne infections—both of which have been targets of broad prevention efforts, with success in some areas, yet major challenges remain. Although substantial progress in reduction of the burden of vaccine-preventable diseases has been made, continued cases and outbreaks of these diseases persist, driven by various contributing factors. Worldwide, emerging and reemerging infections continue to challenge prevention and control strategies while the growing problem of antimicrobial resistance needs urgent action. An important priority for control of infectious disease is to ensure that scientific and technological advances in molecular diagnostics and bioinformatics are well integrated into public health. Broad and diverse partnerships across governments, health care, academia, and industry, and with the public, are essential to effectively reduce the burden of infectious diseases. Elsevier Ltd. 2014 2014-07-01 /pmc/articles/PMC7137922/ /pubmed/24996590 http://dx.doi.org/10.1016/S0140-6736(14)60890-4 Text en Copyright © 2014 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Khabbaz, Rima F Moseley, Robin R Steiner, Riley J Levitt, Alexandra M Bell, Beth P Challenges of infectious diseases in the USA |
title | Challenges of infectious diseases in the USA |
title_full | Challenges of infectious diseases in the USA |
title_fullStr | Challenges of infectious diseases in the USA |
title_full_unstemmed | Challenges of infectious diseases in the USA |
title_short | Challenges of infectious diseases in the USA |
title_sort | challenges of infectious diseases in the usa |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137922/ https://www.ncbi.nlm.nih.gov/pubmed/24996590 http://dx.doi.org/10.1016/S0140-6736(14)60890-4 |
work_keys_str_mv | AT khabbazrimaf challengesofinfectiousdiseasesintheusa AT moseleyrobinr challengesofinfectiousdiseasesintheusa AT steinerrileyj challengesofinfectiousdiseasesintheusa AT levittalexandram challengesofinfectiousdiseasesintheusa AT bellbethp challengesofinfectiousdiseasesintheusa |